Stephen Freedland, MD, is director of the Center for Integrated Research in Cancer and Lifestyle, co-director of the Cancer Genetics and Prevention Program and associate director for faculty development at the Cancer Institute. He is a faculty physician in the Division of Urology at the Cedars-Sinai Surgery Department. Freedland's clinical expertise focuses on urological diseases, particularly benign prostatic hyperplasia and prostate cancer.
- Specializes in prostate cancer prevention, management and outcomes
- Increase our knowledge of the interaction between nutritional carbohydrates and prostate cancer.
- The Freedland Lab is also using an in vivo model to look at the effects of cholesterol signaling reduction and restoration on castration-resistant prostate cancer.
Learn more about the scientists, faculty members, investigators and other healthcare professionals of the Freedland Laboratory, whose dedicated efforts lead to groundbreaking discoveries.
Branche BL, Howard LE, Moreira DM, Roehrborn C, Castro-Santamaria R, Andriole GL, Hopp ML, Freedland SJ.
J Urol. 2018 Feb;199(2):536-542.
Jamnagerwalla J, Howard LE, Allott EH, Vidal AC, Moreira DM, Castro-Santamaria R, Andriole GL, Freeman MR, Freedland SJ.
Prostate Cancer Prostatic Dis. 2017 Dec 27.